A detailed history of D. E. Shaw & Co., Inc. transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 25,738 shares of FHTX stock, worth $207,705. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,738
Holding current value
$207,705
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$5.05 - $8.0 $129,976 - $205,904
25,738 New
25,738 $147,000
Q2 2022

Aug 15, 2022

SELL
$8.48 - $16.84 $168,370 - $334,358
-19,855 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$8.87 - $22.1 $50,443 - $125,682
5,687 Added 40.14%
19,855 $302,000
Q4 2021

Feb 14, 2022

BUY
$10.79 - $22.87 $152,872 - $324,022
14,168 New
14,168 $324,000

Others Institutions Holding FHTX

About Foghorn Therapeutics Inc.


  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $336M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.